Insulet
PODD
#1631
Rank
S$17.23 B
Marketcap
S$244.82
Share price
-4.25%
Change (1 day)
-21.90%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): S$0.51 Billion

According to Insulet's latest financial reports the company's current earnings are S$2.70 Billion. , an increase over its 2024 earnings that were of S$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 S$0.50 B16.27%
2024 S$0.43 B36.76%
2023 S$0.31 B481.9%
2022 S$54.86 M-45.24%
2021 S$0.10 B43.35%
2020 S$69.88 M18.51%
2019 S$58.97 M41.16%
2018 S$41.77 M-711.95%
2017 -S$6.83 Million-56.85%
2016 -S$15.83 Million-79.31%
2015 -S$76.49 Million63.85%
2014 -S$46.68 Million31.04%
2013 -S$35.63 Million-21.96%
2012 -S$45.65 Million
2010 -S$43.54 Million-42.38%
2009 -S$75.56 Million-33.56%
2008 -S$0.12 Billion65.93%
2007 -S$68.54 Million209.75%
2006 -S$22.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$42.70 B 8,313.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.77 B 2,022.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$7.98 B 1,473.72%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
S$32.75 B 6,352.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-S$0.27 Billion-151.39%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
S$0.12 B-75.50%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
S$1.40 B 177.51%๐Ÿ‡บ๐Ÿ‡ธ USA